Search

Your search keyword '"Hess G."' showing total 66 results

Search Constraints

Start Over You searched for: Author "Hess G." Remove constraint Author: "Hess G." Publisher springer nature Remove constraint Publisher: springer nature
66 results on '"Hess G."'

Search Results

1. Temsirolimus acts as additive with bendamustine in aggressive lymphoma.

2. Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma.

3. Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting.

4. The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia.

5. The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)

6. Radioimmunotherapy – still experimental? Rational, proven indications and future trends.

7. Sakroplastie zur Behandlung von Insuffizienzfrakturen des Sakrums.

8. Reply to “Comments on: The Neutral, Barotropic Planetary Boundary Layer Capped by a Low-level Inversion”.

9. The Australian Air Quality Forecasting System: Exploring First Steps Towards Determining The Limits of Predictability For Short-Term Ozone Forecasting.

10. Immuntherapie maligner Non-Hodgkin-Lymphome.

11. Selection of 2'-fluoro-modified RNA aptamers for alleviation of cocaine and MK-801 inhibition of the nicotinic acetylcholine receptor.

12. The Neutral, Barotropic Planetary Boundary Layer, Capped by a Low-Level Inversion.

13. Evaluating Models of The Neutral, Barotropic Planetary Boundary Layer using Integral Measures: Part I. Overview.

14. Evaluating Models Of The Neutral, Barotropic Planetary Boundary Layer Using Integral Measures: Part Ii. Modelling Observed Conditions.

15. Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL.

16. Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach.

17. Facilitation of long-term potentiation in layer II/III horizontal connections of rat motor cortex following layer I stimulation: route of effect and cholinergic contributions.

18. Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with Type B hepatitis.

19. Hepatitis-B virus-associated deoxyribonucleic acid polymerase: A partial characterization by the use of chemical agents.

20. Comparison of indicators for dane particles.

21. Die Ausbreitung von Hepatitis-B-Infektionen in Familien HBAg-positiver Träger.

22. Anti-HB, HBAg and DNApolymerase activity in healthy HBAg carriers and patients with inflammatory liver diseases.

23. Die Charakterisierung des klinisch gesunden Hepatitis-B-Antigen (HBAg)-Trägers.

24. The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HBAg), hepatitis-B-core-antigen (HBAg) and IgG for the classification of inflammatory liver diseases.

25. Quantal analysis of long-term posttetanic changes in minimal postsynaptic potentials of hippocampal slices in vitro.

26. Quantal analysis of long-term potentiation of combined neuronal postsynaptic potentials on hippocampal slices in vitro.

27. Antibodies to hepatitis B virus x-protein in sera of patients with acute and chronic acitve hepatitis.

28. Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents.

29. In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor.

30. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination.

32. Demonstration of antibodies to the surface (anti-p41) and core proteins (anti-p24) of the human immunodeficiency virus (HIV) in individuals positive for anti-HIV.

33. Hepatitis B and C in heterosexual patients with various sexually transmitted diseases.

34. Quantal parameters of 'minimal' excitatory postsynaptic potentials in guinea pig hippocampal slices: binomial approach.

35. Statistical analysis of long-term potentiation of large excitatory postsynaptic potentials recorded in guinea pig hippocampal slices: binomial model.

36. Quantal analysis of long-term potentiation of 'minimal' excitatory postsynaptic potentials in guinea pig hippocampal slices: binomial approach.

37. Chronic viral hepatitis B in childhood. II. Immunological studies in serum and liver tissue and family studies.

39. Single-channel current recordings of acetylcholine receptors in electroplax isolated from the Electrophorus electricus Main and Sachs' electric organs.

40. Modification of the immune response against hepatitis B virus by the human immunodeficiency virus.

41. Spektrum und Zeeman-Effekt des dreiwertigen Praseodyms im hexagonalen Äthylsulfat.

47. Diäthylenglykol.

50. Generating confidence intervals for composition-based landscape indexes

Catalog

Books, media, physical & digital resources